Q
QuantAbundanceAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

30,464 signal articles · 150 in last 24h · 154,171 total before filter · latest 1h ago
150last 24h
875last 7d
144● bullish (7d)
96● bearish (7d)
214publishers
AllMacro211Earnings109M&A125Regulatory21Product21Analyst18
✕ clear all filtersticker: AXPSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Nebius and Vantage Plan Nvidia-Powered AI Infrastructure Deployment in South Wales
InvestorsHub42d agoneutral
Nebius and Vantage Plan Nvidia-Powered AI Infrastructure Deployment in South Wales

Vantage Data Centers (AMEX:VNTG) and Nebius (NASDAQ:NBIS) have agreed to deploy Nvidia-powered artificial intelligence infrastructure at Vantage’s CWL1 data centre campus in Newport, Wales, expanding the region’s role in the UK’s growing AI infrastructure market. The agreement represents the first announced commercial capacity commitment within the South Wales AI Growth Zone.

Why Delta and United’s Loyalty Programs Could Be Worth $30 Billion
Barrons.com43d agoneutral
Why Delta and United’s Loyalty Programs Could Be Worth $30 Billion

Air Canada sold the 25% Aeroplan program stake to Blackstone and some leading Canadian institutional investors, valuing the program at more than $7 billion U.S. dollars ($10 billion Canadian dollars), according to a news release Tuesday. Based on the valuation of the Aeroplan stake, the Delta SkyMiles and United MileagePlus loyalty programs could each be worth $30 billion or more, which would be a significant chunk of each airline’s market values, Jefferies analyst Sheila Kahyaoglu wrote after the sale.

Forget big tech: the real AI money is in plumbing
Yahoo Finance Video43d agoneutralVIDEO
Forget big tech: the real AI money is in plumbing

Host Kenny Polcari joins Yahoo Finance's Jared Blikre and Founder ETFs' Michael Monaghan to explore the data showing why founder-led companies significantly outperform the market. The panel also breaks down the flawless execution of the SpaceX IPO, the overlooked opportunities in AI infrastructure, and why the next major productivity boom will mirror the historical shift from steam to electricity.

American Express (AXP) Stock Still Looks Cheap After A 120% Five Year Run
Simply Wall St.44d agoneutral
American Express (AXP) Stock Still Looks Cheap After A 120% Five Year Run

American Express has delivered a 120.0% share price return over the past five years, while the latest intrinsic value estimate using the Excess Returns model still points to the stock trading below that intrinsic value. At the same time, traditional earnings multiples look roughly in line with the market. Over five years, American Express shares are up 120.0%, which puts recent short term weakness this year into the context of a strong longer term run. Recent attention on American Express as...

American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus
Simply Wall St.47d agoneutral
American Express (AXP) Preferred Offering Puts Its Undervalued Narrative Back In Focus

American Express (AXP) has drawn fresh attention after completing a US$1.6b fixed income offering of preferred depository shares, giving investors another lens on the company alongside its common stock performance and recent earnings commentary. See our latest analysis for American Express. Against this backdrop, American Express shares trade at US$340.91, with a 90 day share price return of 7.87% even as the year to date share price return is down 8.54%. The 5 year total shareholder return...

TripAdvisor Q2 Earnings Call Highlights
MarketBeat48d agoneutral
TripAdvisor Q2 Earnings Call Highlights

TripAdvisor (NASDAQ:TRIP) reported second-quarter results in line with its expectations as growth in its experiences business was offset by persistent search-related pressure in legacy offerings and uneven travel demand. The company also said it expects to complete the sale of restaurant reservation

SRX Global Acquires Stake in Vistagen Therapeutics
InvestorsHub51d agoneutral
SRX Global Acquires Stake in Vistagen Therapeutics

SRX Global (AMEX:SRXH) disclosed an investment in Vistagen Therapeutics (NASDAQ:VTGN) and said it intends to engage with the company’s leadership and board on potential shareholder value initiatives. Key Investor TakeawaysSRX Global (AMEX:SRXH) acquired a stake in Vistagen Therapeutics (NASDAQ:VTGN).